Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: A randomized trial.

Kohei KakuYuichiro YamadaHirotaka WatadaAtsuko AbikoTomoyuki NishidaJeppe ZachoArihiro Kiyosue

Published in: Diabetes, obesity & metabolism (2018)

Semaglutide was well tolerated, with no new safety issues identified. Semaglutide treatment significantly reduced HbA1c and body weight vs additional OAD treatment in Japanese people with T2D.

Keyphrases

type diabetes
body weight
cardiovascular disease
metabolic syndrome
combination therapy
insulin resistance
smoking cessation